Cargando…
Ocular Myasthenia Gravis: A Current Overview
Ocular myasthenia gravis (OMG) is a neuromuscular disease characterized by autoantibody production against post-synaptic proteins in the neuromuscular junction. The pathophysiological auto-immune mechanisms of myasthenia are diverse, and this is governed primarily by the type of autoantibody product...
Autor principal: | Behbehani, Raed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911903/ https://www.ncbi.nlm.nih.gov/pubmed/36778719 http://dx.doi.org/10.2147/EB.S389629 |
Ejemplares similares
-
Ocular myasthenia gravis: A review
por: Nair, Akshay Gopinathan, et al.
Publicado: (2014) -
Update on ocular myasthenia gravis in Taiwan
por: Lin, Chao-Wen, et al.
Publicado: (2018) -
Controversies in Ocular Myasthenia Gravis
por: Evoli, Amelia, et al.
Publicado: (2020) -
Current Treatment of Myasthenia Gravis
por: Alhaidar, Mohammed K., et al.
Publicado: (2022) -
Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis
por: Townsel, Courtney, et al.
Publicado: (2016)